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The identification of different pools of cardiac progenitor cells resident in the adult
mammalian heart opened a new era in heart regeneration as a means to restore the
loss of functional cardiac tissue and overcome the limited availability of donor organs.
Indeed, resident stem cells are believed to participate to tissue homeostasis and renewal
in healthy and damaged myocardium although their actual contribution to these processes
remain unclear. The poor outcome in terms of cardiac regeneration following tissue
damage point out at the need for a deeper understanding of the molecular mechanisms
controlling CPC behavior and fate determination before new therapeutic strategies can
be developed. The regulation of cardiac resident stem cell fate and function is likely to
result from the interplay between pleiotropic signaling pathways as well as tissue- and
cell-specific regulators. Such a modular interaction—which has already been described in
the nucleus of a number of different cells where transcriptional complexes form to activate
specific gene programs—would account for the unique responses of cardiac progenitors
to general and tissue-specific stimuli. The study of the molecular determinants involved in
cardiac stem/progenitor cell regulatory mechanisms may shed light on the processes of
cardiac homeostasis in health and disease and thus provide clues on the actual feasibility
of cardiac cell therapy through tissue-specific progenitors.
Keywords: cardiac stem cell, heart regeneration, cell signaling, differentiation, stem cell homeostasis
INTRODUCTION
Early pre-clinical and clinical trials involving skeletal myoblasts
(Menasché et al., 2008), mesenchymal (Dixon et al., 2009) and
hematopoietic stem cells (Balsam et al., 2004; Murry et al.,
2004) proved mild, non-reproducible effects on cardiac diseases.
In fact, the intracoronary delivery of bone marrow mesenchy-
mal stem cells (MSCs) in patients affected by acute myocar-
dial infarction (AMI) only proved their worth improving left
ventricular ejection fraction by 3%, while failing to modify
the negative impact of ventricular remodeling. In the case of
chronic heart failure (CHF), skeletal myoblast or bone mar-
row mononuclear cell implantation failed to provide any benefit
to the patient, other than a small improvement ascribed to
the secretion of beneficial factors. A different scenario appears
when the outcome of the pathology can be improved by neo-
angiogenesis, like in the case of refractory angina (RA). In this
case, bone marrow cells (namely CD34+ hematopoietic pro-
genitors) can provide some degree of endothelial differentiation
together with the positive paracrine effect to help the cause
(Menasché, 2011).
Anyway, the rate of transdifferentiation obtained by bone mar-
row or skeletal muscle-derived progenitors is limited. Thus, car-
diac resident progenitor cells (CPCs) are considered the elective
source of autologous contractile cells for transplantation (Chugh
et al., 2012). Among adult cardiac resident stem cells, the few
subsets identified on the basis of the expression of c-kit (CD117,
Quaini et al., 2002) or Stem Cell Antigen 1 (Sca-1, Bailey et al.,
2012) are still questioned for their actual role in contractile tissue
homeostasis and regeneration.
Despite the incredible amount of information regarding the
role of specific signaling pathways acting during cardiogenesis to
finely control cell specification within the forming organ, little is
known about the molecular mechanisms governing adult tissue-
specific progenitor cell function.
The issue of tissue-resident stem cell fate and function control
has been so far addressed by using the instruments and knowledge
coming from the study of somatic cells.
Nonetheless, compelling evidence supports the notion that
tissue-resident stem cell behavior and fate may be, at least in
part, modulated through non-canonical stimuli able to activate
cell-specific signaling pathways and in turn leading to a given
biological response (Guilak et al., 2009; Kaivosja et al., 2012).
The organogenesis and healing programs present a high degree
of complexity because of the precise spatial and temporal activa-
tion of signaling pathways that are deemed to interact with each
other.
In the present review, we would like to draw the attention on
the possibility that the regulation of cardiac resident stem cell fate
and function is the result of the interplay between pleiotropic sig-
naling pathways and cell-specific regulators. Thus we summarize
the main pathways acknowledged to participate in the regulation
of adult CPC fate and function so far.
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Wnt SIGNALING PATHWAY
Many biological processes occurring in cardiac stem cells, includ-
ing cardiac specification, survival and differentiation, have been
associated to Wnt signaling pathway (Flaherty et al., 2012). Wnt
signals consist of secreted glycoproteins acting in a paracrine
fashion by binding to Frizzled (FZD) family of trans-membrane
receptors and activating the so-called canonical or non-canonical
transduction pathways.
Different co-receptors are independently activated in response
to canonical (LRP-5/LRP-6) or non-canonical (ROR2 and RYK)
signaling (Katoh and Katoh, 2007) and intracellular Wnt signal-
ing regulators are also involved in the transduction of one or
the other pathway. β-catenin is the main effector of canonical
Wnt signaling whereas non-canonical Wnt signals are transduced
through the Rho/Rac/JNK-dependent or the calcium-dependent
signaling cascades.
Wnt pathways play a role in the development and differenti-
ation of both the embryo and adult heart and are highly inter-
connected. The nuclear translocation of β-catenin was proven to
up-regulate the transcription of genes controlling CPC amplifica-
tion (e.g., c-myc and cyclin D1). On the other hand, the inhibition
of β-catenin-dependent transcription via proteasomal degrada-
tion of its cytoplasmic form triggers CPC differentiation toward
the contractile phenotype (Bergmann, 2010).
Although no evidence has been provided regarding the activa-
tion of β-catenin signaling in the healthy adult heart (Cohen et al.,
2008), this pathway is being activated after myocardial infarction
(Bergmann, 2010). Interestingly, β-catenin depletion is beneficial
to infarcted post-natal mouse heart leading to both attenuated
mortality and LV remodeling. It also up-regulates the expres-
sion of Tbx5 and GATA4 cardiac lineage markers while enhancing
Sca-1+ resident cardiac progenitor cell terminal differentiation
(Zelarayan et al., 2008).
Consistently Krueppel-like factor 15 (KLF15)—a transcription
factor regulating cardiac β-catenin transcriptional activity—was
found to be critical in controlling CPC homeostasis. In fact, the
in vivo proliferative and cardiogenic potential of Sca-1+ CPCs
was reduced in hearts derived from Klf15-/- mice in normal
and hypertrophic conditions. Additionally, the activation of β-
catenin-dependent transcription upon loss of KLF15 prompted
the CPCs toward an endothelial phenotype (Noack et al., 2012).
Following this experimental evidence, Wnt/β-catenin signal-
ing inhibition via the local release of effective Wnt scavengers
or inhibitors (e.g., soluble frizzle-related proteins sFRPs and the
secreted protein Dkk1) has become an attractive therapeutic
target to prevent heart failure and preserve cardiac function.
Moreover the reactivation of Wnt pathway could be explored
as a suitable strategy to protect adult c-kit+ CPCs from oxidative
stress-mediated apoptosis in infarcted heart (Liu et al., 2013) and
restore LV function (Bergmann, 2010).
More recently, a biphasic function for Wnt/β-catenin signal-
ing during cardiac development has been also proposed, implying
that the effects of Wnt signals (including Wnt1, Wnt2a, Wnt3a,
and Wnt8) or their inhibitors can depend on the stage of devel-
opment (Naito et al., 2006; Tzahor, 2007; Ueno et al., 2007).
Studies on the role of Wnt/β-catenin signaling during car-
diac tissue specification demonstrated that the upregulation of
Wnt/β-catenin signaling is essential to the formation of meso-
dermal tissue (Huelsken et al., 2000) and to enhance the cardiac
commitment or the expansion of cardiac progenitors during the
early phases of cardiogenesis (Qyang et al., 2007; Lindsley et al.,
2008).
At a later stage, the inhibition of Wnt/β-catenin signals, medi-
ated by the early cardiac-specific marker Mesp1, is pivotal for the
terminal differentiation of precursors into cardiomyocytes (David
et al., 2008).
Noteworthy, the Wnt/β-catenin signaling seems also to
inhibit early cardiac commitment of progenitors via a non-cell-
autonomous mechanism, very likely to be exerted through the
release of signals by the associated endoderm in mouse ES cells
and embryos (Lickert et al., 2002; Liu et al., 2007). As such, Wnt
signals would participate in cardiac specification and differentia-
tion through several phases of activation and inhibition (Gessert
and Kuhl, 2010) as well as in the regulation of cell-cell interaction
through the involvement of secondary factors acting on cardiac
mesoderm formation during heart development. In this respect,
the effects of this universal pathway would be the result of its
interaction with cell-specific adaptors, thus leading to a context-
and cell-specific response.
For instance, a positive effect on the proliferation of neonatal
and embryonic Isl-1+ CPCs from both in vivo and ex vivo explants
was exerted by Wnt/β-catenin signaling through the downstream
activation of multiple FGF ligands, in particular FGF10 (Cohen
et al., 2007). In contrast, an excess of β-catenin signaling as a
result of the up-regulation of insulin-like growth factor-binding
protein 3 (IGFBP3) was associated to the reduction of the pro-
liferative capacity in adult cultured Sca-1+/Islet-1- cardiac stem
cells (Oikonomopoulos et al., 2011).
Recently, an increased β-catenin activity mediated by stro-
mal cell derived factor 1α (SDF1α) has been associated with
a reduction in c-kit+ CPCs proliferation. This event might
restrain heart endogenous reparative response following con-
ditions (stress or injury) characterized by high levels of the
cytokine (Dimova et al., 2014). The reduction of prolifera-
tion in response to β-catenin activation might be suggestive
of cardiac commitment/differentiation of tissue-specific pro-
genitors. In accordance with this hypothesis, loss-of function
experiments established an undisclosed relationship between
Sca-1 antigen and canonical Wnt signaling in regulating the
balance between c-kit+ CPC proliferation and differentiation.
In fact, c-kit+ CPCs from Sca-1-knockout models exhibited
poor proliferation and increased cardiogenic commitment, very
likely due to the activation of β-catenin signaling (Bailey et al.,
2012).
In contrast to canonical Wnt signaling, non-canonical path-
way is less well characterized and its role in cardiac stem cell
biology remains to be elucidated. Several studies have evidenced
a positive effect of non-canonical Wnt signaling in mouse ES
cell differentiation (Cohen et al., 2008), with Wnt5a and Wnt11
being requested to promote cardiac differentiation through non-
canonical pathway in both the embryo and progenitor cells
(Eisenberg and Eisenberg, 1999; Pandur et al., 2002; Brade et al.,
2006; Palpant et al., 2007; Flaherty and Dawn, 2008; Cohen et al.,
2012).
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Current evidence suggests that some degree of overlapping
exists between the two pathways, although the actual relevance
of this interaction in cardiac tissue formation and repair remains
poorly understood.
NOTCH SIGNALING PATHWAY
Notch pathway is involved in the regulation of tissue homeostasis
and formation during embryonic and adult life by controlling cell
fate decision and themaintenance and differentiation of stem cells
(Nemir and Pedrazzini, 2008). Notch activity participates in car-
diogenesis at multiple stages, from the commitment of mesoderm
to the maturation of myocytes, in a context- and time-dependent
fashion (Gude and Sussman, 2012).
In the developing heart, Notch regulates ventricular trabecu-
lation, cardiomyocyte proliferation and differentiation, as well as
valve formation (High and Epstein, 2008).
Interestingly, both the over-expression and inhibition of Notch
signaling have been associated with the onset of cardiac defects
(Kratsios et al., 2010), pointing at its fine regulation as a key
determinant in fetal heart development.
In mammals, Notch pathway mediates the interaction between
adjacent cells expressing Notch receptors (Notch1–4) and their
ligands (Delta-like 1, 3, 4, and Jagged 1, 2) (Chiba, 2006; Bolós
et al., 2007).
Consequently, the fate and function of any given cell are
strictly regulated by adhesive intercellular interactions and depen-
dent on the fate of the neighboring cells. Upon the binding of
the ligand, Notch intra-cytoplasmic domain (NICD) is released
by proteolytic cleavage, can translocate to the nucleus, interact
with DNA-binding proteins and participate in the control of
downstream effectors.
The most well-known downstream effectors of Notch path-
way are Hes and Hes-related (Hesr) family of proteins, acting
as repressors of the transcription of Notch-dependent genes (Iso
et al., 2003).
In the post-natal heart, Notch1 is the predominant isoform,
being expressed in immature cardiomyocytes and non-myocyte
cells (Croquelois et al., 2008; Gude et al., 2008; Nemir and
Pedrazzini, 2008). The activation of this pathway in adult heart
evokes pro-survival, proliferative and anti-apoptotic effects in
cardiomyocytes, thus contributing to attenuate cardiac hyper-
trophy, fibrosis and ameliorate cardiac performance (Croquelois
et al., 2008; Nemir et al., 2012).
Together with its target gene Hes-1, Notch pathway was
found up-regulated in cardiomyocytes at the border zone of
the infarcted region (Gude et al., 2008) and also cardiomyocyte
treatment with hepatocyte growth factor (HGF), exerting cardio-
protective effects through its receptor c-Met, was found to act
through the activation of Notch signaling.
NICD over-expression in the infarcted heart caused functional
and morphological improvement, although no information on
the possible contribution of resident stem cells to this process was
given. Nonetheless, since c-kit+ and Sca-1+ cardiac progenitors
express c-Met receptor and secrete HGF (Urbanek et al., 2005),
the homeostasis of the adult myocardium might, at least in part,
be guided by the activation of Notch pathway in undifferentiated
cells homing to the damaged site.
Consistently, evidence is being accumulated suggesting that
resident CPC recruitment and differentiation is an effect of
Notch-mediated induction of reparative mechanisms in the dam-
aged adult myocardium (Campa et al., 2008; Gude et al., 2008;
Kratsios et al., 2010; Li et al., 2010).
Additionally, cycling CPCs displayed high Notch activity as a
means to restrict their cardiomyocyte differentiation potential,
thus predicting for Notch a role in maintaining the self-renewal
and stemness state of the cardiac precursor pool residing inmouse
and rat normal adult hearts (Collesi et al., 2008; Croquelois et al.,
2008).
This result paralleled those obtained in embryonic stem cells
in which the activation of Notch signaling hindered the differen-
tiation of mesodermal progenitors into cardiomyocytes (Nemir
et al., 2006; Schroeder et al., 2006). Furthermore, in a late stage of
the hypertrophic response, Jagged-1 ligand expression was found
up-regulated on the membrane of cardiomyocytes: this event was
shown to affect the expansion of the neighboring Notch-positive
cardiomyocytes and progenitor cells.
However, these results were obtained in a non-purified pop-
ulation of cardiac stem/progenitor cells, exclusively selected for
their lack of markers of terminal differentiation.
The in vivo analyses of adult murine cardiac tissue highlighted
an interesting pattern in Notch distribution: a baseline expres-
sion of Notch-1 receptor in c-kit+ CPCs residing in cardiac niche
was confirmed. As expected, these cells are surrounded by cells
expressing Jagged-1 ligand. A similar correlation between Notch-
1 and Sca-1 expression in stem cell niche has been also suggested
(Boni et al., 2008).
Although these data seem to imply a linear dependence of stem
cell niche regulation by the surrounding tissue, a more sophis-
ticated Notch-based mechanism has been shown to regulate the
balance between the proliferation and differentiation in cardiac
stem cells, thus questioning the actual role of Notch on the main-
tenance of stemness phenotype. In fact, upon Jagged-1-mediated
stimulation, Notch-1 activation paralleled the up-regulation of
Nkx-2.5, an early regulator of cardiac commitment, driving the
cell toward a phenotype of highly proliferative myocytes.
These results would provide evidence of the existence of a
modular interplay between the ubiquitous Notch pathway and
cell-specific actuators (Nkx-2.5) to evoke a unique response of
cardiac progenitors to external stimuli.
In the border zone of the infarcted myocardium, the phar-
macological inhibition of Notch reduced the number of cycling
c-kit+ CPCs and compromised their cardiac commitment.
Accordingly, a severe dilated myopathy developed in newborn
mice following the inhibition of Notch signaling, as a conse-
quence of the reduced differentiation rate of cardiac progenitors
(Urbanek et al., 2010).
The complexity of Notch impact on cardiac progenitor regula-
tion is demonstrated by its role in epicardial cells. Epicardium has
been recently suggested to act as a cardiac stem cell niche con-
tributing to the pool of cardiac progenitors in developing and
adult heart (Zhou et al., 2008; Popescu et al., 2009; Di Meglio
et al., 2010). Indeed MI causes the activation of epicardium-
derived progenitors (Limana et al., 2010) to promote cardiac
repair by contributing to neovascularization and generating
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cardiomyocytes structurally and functionally integrated with the
resident myocardium (Smart et al., 2012).
Notch blockade lead to an up-regulation of pluripotency genes
in epicardial-derived c-kit+ cells from rat hearts and delayed their
differentiation (Zakharova et al., 2012). In particular, Notch sig-
naling was found to favor epithelial-to-mesenchymal transition
(EMT) in epicardial precursors in culture.
The transition between an epithelial and mesenchymal cell
phenotype is a crucial and reversible process (mesenchymal-to-
epithelial transition, MET) operating during embryogenesis and
organ development but can also promote the acquisition of stem-
ness properties in vitro (Di Meglio et al., 2010; Forte et al.,
2012). EMT has been found reactivated in adult cells in patho-
logical conditions (Zeisberg et al., 2007; Thiery et al., 2009) and
demonstrated to be crucial in embryonic stem cell differentiation
(Martínez-Estrada et al., 2010).
This process is fundamental in the epicardium contribut-
ing to coronary vasculature and myocardium formation during
heart development (Zhou et al., 2011). At this stage epicardium-
derived cells (EPDCs) undergo three successive rounds of EMT
andMET to acquire the final differentiated phenotype and spatial
organization (Thiery et al., 2009).
Of note, both c-kit+ and c-kit- cardiac progenitor cells migrat-
ing out of atrial explants in vitro were shown to transiently
express epicardial markers and to proceed to EMT in culture.
Different signaling pathways belonging to TGFβ superfamily,
Wnt/β-catenin, Notch, HGF, FGF, retinoic acid families have been
described (von Gise and Pu, 2012; Zakharova et al., 2012) as key
players in the fine regulation of EMT process.
JAK/STAT SIGNALING PATHWAY
The hypothesis that JAK/STAT pathway could be involved in car-
diogenesis has been initially explored in Drosophila. Drosophila
embryos with targeted mutations in the JAK/STAT ligand or
in STAT92E transducer developed non-functional hearts with
defects in lumen formation very likely as an effect of inappropri-
ate cell-cell interaction and abnormal cell aggregation. This effect
has been associated to JAK/STAT pathway regulation of Tinman
protein expression prior to heart precursor cell diversification
(Johnson et al., 2011). Tinman is the Drosophila homolog of Nkx-
2.5 mammalian transcription factor. Thus, the existence of an
interaction between JAK/STAT ubiquitous signaling pathway and
cardiac-specific regulators during tissue-specific stem cell specifi-
cation in mammalians can be inferred, although no evidence has
been given so far.
JAK-STAT signaling has been demonstrated to be essential
for keeping ES self-renewal and pluripotency (Niwa et al., 1998;
Matsuda et al., 1999). The inhibition of JAK2/STAT3 signaling in
embryonic bodies prevented the formation of beating areas, while
its ectopic expression had opposite effects (Foshay et al., 2005).
The same pathway has been found to protect murine car-
diac tissue by different means, the most remarkable being the
mobilization of endothelial progenitors from the bone mar-
row (Mohri et al., 2012). Additionally, a direct effect of this
signaling pathway on cardiac cells was proposed. For exam-
ple, the attenuation of cardiac fibrosis after MI through the
activation of STAT3 by IL-11 in cardiac myocytes has been
demonstrated (Obana et al., 2010). This cytokine, together with
CT-1 was found highly expressed in the heart during myocardial
infarction.
STAT3 pathway was also activated in Sca-1+ cardiac pro-
genitor cells treated with IL-11 and CT-1. The result of such
stimulation on the cells was the up-regulation of endothelial
markers (Mohri et al., 2009). This process is thought to be a
pro-angiogenic response of resident stem cells to the hypoxic and
inflammatory environment of the post-ischemic area.
Surprisingly, a similar effect could not be evoked by the inflam-
matory cytokine IL-6 in Sca-1+ cells, very likely because of the
lack of gp130 receptor on the membrane of this stem cell subset
(Mohri et al., 2012).
On the contrary, JAK-STAT pathway can be activated through
IL-6 receptor in c-kit cardiac stem cells, thereby inducing their
endothelial differentiation. These effects are likely to reflect the
tight association between the inflammatory burst occurring after
myocardial infarction and the process of neo-vascularization.
HIPPO PATHWAY IN CARDIAC STEM/PROGENITOR CELLS
The Hippo pathway has been recently identified as a fundamental
axis in the regulation of organ size and shape during organogen-
esis and its involvement in the pathogenesis of cancer has been
established (Johnson and Halder, 2014).
This pathway negatively controls the nuclear shuttling of
the paralog Yes-associated protein (YAP) and WW domain-
containing transcription regulator protein 1 (WWTR1 or TAZ) by
sequestering them into the cytoplasm and inducing their degra-
dation through proteasome activity (Hong and Guan, 2012).
The downstream effectors of Hippo pathway have also been
identified as mammalian proto-oncogenes.
YAP and TAZ have no transcriptional activity per se but func-
tion as gene co-activators by binding cell-specific transcription
factors (Tian et al., 2010).
YAP/TAZ axis has been described as a central regulator of
human embryonic stem cell self-renewal through the control
of SMAD complex shuttling to the nucleus, with TAZ knock-
down resulting in the loss of cell pluripotency (Varelas et al.,
2010). The same co-factors control intestinal (Camargo et al.,
2007) and neural progenitor cell number and differentiation (Cao
et al., 2008) by targeting the Notch signaling. YAP activity has
also been proven fundamental in controlling epidermal stem cell
homeostasis (Zhang et al., 2011).
The activity of TAZ as a modulator of MSC differentiation
has been shown to direct cell differentiation into osteoblasts and
adipocytes through its ability to bind lineage-specific master tran-
scription factors: in fact, MSC fate could be controlled by TAZ
ability either to activate Runx2 or to inhibit PPARγ, respectively
(Hong et al., 2005; Hong and Yaffe, 2006).
Moreover, the same factor has been demonstrated to be cru-
cial in directing myogenic differentiation by physically associating
with MyoD in skeletal muscle progenitors (Jeong et al., 2010).
Yap1 is an important regulator of cardiomyocyte prolifera-
tion and embryonic heart development, its lack being associated
with diminished cardiomyocyte proliferation (von Gise et al.,
2012) and embryonic lethality (Heallen et al., 2011) during
cardiogenesis.
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In the adult heart, Hippo pathway has been connected to car-
diomyocyte response and protection against ischemic injury (Del
Re et al., 2013).
Our group recently identified the role of YAP/TAZ proteins as
regulators of cardiac stem/progenitor cell sensitivity to the stiff-
ness and nanotopography of the microenvironment (Mosqueira
et al., 2014).
By using human and murine cardiac resident stem cells iso-
lated on the basis of Stem Cell Antigen 1 (Sca-1) expression, we
demonstrated the ability of YAP and TAZ to translocate from
the cytoplasm to the nucleus and back in response to dynamic
modifications in substrate elasticity and nanostructure.
Similarly to what was shown in mesenchymal stem cells
(Dupont et al., 2011), in Sca-1+ cardiac stem cells, YAP/TAZ
re-localization in the nucleus seems to be controlled by the avail-
ability of adhesion sites within the extracellular matrix (ECM)
and the ability of the cells to spread and acquire a given shape.
Along with their key role in mastering CPC migration,
YAP/TAZ participate in fate decision in tripotent Sca-1+ car-
diac stem/progenitor cells: its inhibition by gene silencing results
in a switch between cardiac and endothelial lineage commit-
ment. According to our unpublished results, a direct interaction
could occur in the cytoplasm between YAP/TAZ protein and
GATA-4, Tbx-5 cardiac-specific transcription factors. This bind-
ing would induce the complex to migrate to the nucleus of
Sca-1+ CPCs and trigger specific responses (our unpublished
results).
PI3K-Akt/Pim-1 KINASE AXIS
Akt is a kinase promoting a number of biological func-
tions including cell survival, proliferation, and differentiation
(Sussman, 2007). Akt is involved in a number of cell processes
as a result of its interaction with different pathways.
The cardiac-specific overexpression of nuclear Akt was found
to increase cell cycling in resident cardiac progenitor cells, an
effect which has been associated with cardioprotective signifi-
cance (Fujio et al., 2000; Shiraishi et al., 2004; Gude et al., 2006;
Tsujita et al., 2006).
Through ectopic expression experiments, Akt has been
deemed responsible of the paracrine effect implanted mesenchy-
mal stem cells exert on injured cardiac tissue. The molecular basis
of this effect has been ascribed to the ability of Akt-transduced
MSCs to secrete amassive amount of beneficial molecules, namely
VEGF, bFGF, HGF, IGF-1, and thymosin β4 (TB4), thus evoking
cardiac tissue remodeling and local neo-vascularization (Gnecchi
et al., 2008). In this context, a possible effect of the factors secreted
on the resident pool of cardiac stem/progenitor cells has been
hypothesized.
Recently, the cooperation between Akt and Pim-1 kinases has
been identified in c-kit+ cardiac progenitor cells. Pim-1 is known
to exert anti-apoptotic effects on the myocardium as a result of
the phosphorylation of Bad and inhibition of caspase cleavage
(Muraski et al., 2007).
Also, Pim-1 kinase phosphorylates heterochromatin protein-1
and nuclear mitotic apparatus protein (NuMA), which are crucial
in cell division, while promoting cell proliferation in cancer and
hematopoietic stem cells (Sun and Schatten, 2006) through the
collaboration with c-Myc (Stewart et al., 1999; Zhang et al., 2007,
2008).
In c-kit+ cardiac stem cells, Pim-1 over-expression was found
to enhance CPC proliferation through asymmetric division, with
Pim-1 transgenic mice displaying a higher proliferative activity in
the heart as compared to the controls (Cottage et al., 2010).
A hypothesis on the role of Pim-1 kinase has been formulated
in which its overexpression is responsible for CPC increased pro-
liferation during the hyperplastic phases occurring in physiologi-
cal (during pre- and post-natal development) and in pathological
(after myocardial infarction) conditions.
HGF AND IGF1 IN CARDIAC STEM CELLS
The possible role of Hepatocyte Growth Factor (HGF) and
Insulin-like Growth Factor-1 (IGF-1) in the homeostasis and dif-
ferentiation of resident cardiac stem cells has been the subject of
a few investigations in which they were studied together.
Hepatocyte growth factor (HGF) is a pleiotropic cytokine of
mesenchymal origin, promoting motility, proliferation, invasion,
morphogenesis, and survival in a wide spectrum of cells, namely
epithelial and endothelial cells (Trusolino and Comoglio, 2002;
Birchmeier et al., 2003). HGF controls the tubulogenesis during
kidney (Santos et al., 1994) and mammary gland (Yang et al.,
1995) development and angiogenesis (Bussolino et al., 1992).
The protein, originally identified as scatter factor (SF), acts as a
chemoattractant for motor neuron axon (Ebens et al., 1996) and
myogenic precursors (Bladt et al., 1995; Maina et al., 1996) and
a survival factor for hepatocytes (Schmidt et al., 1995) and pla-
centa (Uehara et al., 1995). Our group identified the presence
of HGF putative receptor c-Met on murine mesenchymal stem
cells and successfully achieved MSC commitment toward cardiac
phenotype through HGF stimulation. The cells failed to acquire
a mature cardiomyocyte phenotype by our protocol (Forte et al.,
2006). In this study, HGF activity in MSCs was shown to activate
the ras-ERK1/2 and p38MAPKs as well as the PI3K/Akt pathways.
Consistently, HGF has been shown to improve embryonic stem
cell differentiation toward the cardiac phenotype (Roggia et al.,
2007).
HGF has a cardioprotective role in experimentally induced
myocardial infarction, preventing cardiomyocyte apoptosis,
inducing angiogenesis, and improving impaired heart function
(Aoki et al., 2000; Jayasankar et al., 2003; Sala and Crepaldi, 2011).
c-kit+ cardiac resident stem cells were shown to secrete HGF
while expressing its functional receptor on their membrane. The
factor acts as a chemoattractant and increases c-kit+ cardiac stem
cell invasive ability. This cell subset was shown to express a func-
tional receptor for IGF-1, while its administration had few, if any,
motogenic or invasive activity on them. Interestingly, IGF-1 dis-
played a marked anti-apoptotic activity in CSCs (Urbanek et al.,
2005).
Insulin-like growth factor-1 (IGF-1) is a potentmitogen, exerts
anti-apoptotic activity, and is necessary for neural stem cell
growth (Arsenijevic et al., 2001). IGF-1 also promotes myocyte
formation while protecting them from the injury due to myocar-
dial infarction (Li et al., 1997). Moreover, the proliferation and
cardiac induction of developing murine mesoderm could be
promoted in vitro by administering IGF, thus disclosing a novel
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role of this cytokine in cardiac mesoderm specification (Engels
et al., 2014).
Both IGF-1 and HGF, whose expression was found signifi-
cantly increased in the infarction border zone after myocardial
ischemic insult (Fiaccavento et al., 2005), were shown to enhance
cardiac stem cell proliferation. The local delivery of both the fac-
tors in the infarcted heart resulted in the migration of c-kit+
cardiac stem cells toward the injured area and the regeneration
of dead portions of the myocardium (Urbanek et al., 2005).
Moreover, the regenerative response of endogenous porcine
c-kit+/CD45− cardiac stem cells to an ischemic insult could be
enhanced in situ by administering the two growth factors directly
through the coronary circulation (Ellison et al., 2011). This treat-
ment resulted in a persistent dose-dependent and positive effect
on cardiac performance, probably due both to a direct effect on
the survival of the cardiomyocytes and to an enhancement in
cardiac stem cell function.
EXAMPLES OF THE INTERACTION BETWEEN DIFFERENT
PATHWAYS IN CARDIAC PROGENITOR CELLS
The interplay among the molecular pathways taking part to car-
diogenesis could be based on the sharing of molecular effectors,
with WNT/β-catenin, Hippo, TGF β and BMP signaling being
considered pivotal in the specification and maturation of cardiac
precursors (Attisano and Wrana, 2013).
An example of such an interplay comes from the use of
conditional mutagenesis inmouse embryos. By this means, a hier-
archical regulation of cardiac progenitor differentiation has been
unveiled, in which WNT/β-catenin acts as downstream effec-
tor of Notch signaling and upstream of BMP signaling during
embryonic heart development (day 9.0). In this context, pro-
genitor cardiac differentiation requires the sequential expression
of distinct sets of cardiac transcription factors controlled by
WNT/β-catenin and Bmp4 signaling. At an early stage WNT/β-
catenin activates Baf60c, Nkx2-5, and Isl1 genes but also BMP4
signaling which, in turn, activates Gata4 and SRF (Klaus et al.,
2012).
Similarly, the Hippo pathway effector TAZ has been shown to
negatively regulate WNT pathway by inhibiting Disheveled, an
upstream inhibitor of the β-catenin destruction complex, thus
reducing β-catenin stabilization in human embryonic kidney cells
(Varelas et al., 2010). Therefore, Hippo pathway appeared to
restrict WNT/β-catenin signaling by TAZ cytoplasmic activity
(Varelas et al., 2010). The interaction between Hippo and WNT
signaling pathways has also been acknowledged as part of the
complex mechanisms controlling mammalian heart size, with
the first antagonizing the nuclear β-catenin/YAP interaction in
differentiating cardiomyocytes (Heallen et al., 2011).
Lately, a study by Azzolin and co-workers proposed a new
model in which WNT/β-catenin signaling responses are being
mediated, in a context-dependent manner, not only by β-catenin
activation, but also by TAZ stabilization and TAZ-dependent
transcription, thus suggesting TAZ as downstream co-activator
of β-catenin target genes (Azzolin et al., 2012). This study also
revealed a Hippo inhibitory activity of β-catenin, inducing TAZ
inhibition through its interaction with proteasomal complex.
Although these findings comemainly from studies on cancer cells,
similar interaction might positively or negatively regulate cardiac
stem cells where both β-catenin and TAZ have been demon-
strated to be instrumental to the self-renewing and differentiation
processes.
Another example of how the interaction of known signaling
pathways can affect the regulation of cardiac progenitors is given
in mouse embryos, where the ablation of Notch1 in Islet1+ CPCs
FIGURE 1 | Universal signaling pathways and cell-specific actuators
interact in cardiac stem cells to induce given biological responses. The
interaction of universal determinants (in red) and stage-specific actuators
(in blue) in adult cardiac progenitor cells (CPCs) is schematically
represented (A). Yellow boxes identify the signaling pathways so far
recognized to participate in CPCs function. The association with CPC
specific receptors has been found for some of the pathways, while for
others no clear evidence of any interaction with cell-specific determinants
has been given so far (indicated by question marks). The participation of
well-known signaling pathways to given activities in adult cardiac
progenitor cells is shown in (B). Please refer to the main text for the
meaning of the abbreviations.
Frontiers in Physiology | Striated Muscle Physiology July 2014 | Volume 5 | Article 219 | 6
Pagliari et al. Signaling pathways in cardiac stem cells
triggers their expansion by negatively regulating Wnt canonical
signaling and thus increasing the levels of active β-catenin pro-
tein. The subsequent inhibition in their cardiac differentiation is
reported (Kwon et al., 2009; Andersen et al., 2012). Further stud-
ies will be required to confirm such data in adult cardiac stem
cells.
CONCLUSIONS AND FUTURE PERSPECTIVES
In conclusion, studying the regulation of adult cardiac stem cell
homeostasis and differentiation could require a higher degree of
complexity. Few studies have highlighted a complex network of
interactions among several signaling cascades contributing to the
control of cardiac specification.
Therapeutic approaches trying to enhance the impact of car-
diac regeneration or involving the differentiation of resident
cardiac progenitor cells will also benefit from the knowledge
produced. A graphical representation of such interactions occur-
ring in the context of adult cardiac progenitor cells is shown in
Figure 1.
In fact, investigations aimed at highlighting the interaction
between universal signaling pathways and stage-specific determi-
nants are overseen as a promising perspective to design novel
approaches to the treatment of cardiac diseases. A context-specific
system is already considered a dogma as referred to the nucleus
of different cell types, where pleiotropic transducers physically
interact with cell-specific transcription factors (adaptors) to evoke
unique responses in terms of gene program activation (Andel
et al., 1999).
While apparently multiplying the complexity of the regulatory
mechanisms presiding at cardiac stem cell homeostasis, the idea
that such a modular interaction exists provides a hub for bio-
chemical and high-throughput studies to unveil the nature and
function of such mechanisms and help to design strategies to
control cardiac stem cell function in a clinical perspective.
For example, the context-specific activity of intracellular effec-
tors can be selectively tuned by changes in the mechanics of
tissue-specific extracellular milieu, like in the case of Hippo
pathway transducers affecting cell responses (growth, prolifera-
tion and differentiation) through the modification of the cellular
genetic program (Mendez and Janmey, 2012; Mosqueira et al.,
2014).
Understanding and reproducing this extremely sophisticated
level of control will be vital to the success of cardiac regenerative
therapies in the next future (Lutolf et al., 2009).
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